Adar Poonawalla commits 100 million doses of vaccines every year to Biocon Biologics
3 years, 3 months ago

Adar Poonawalla commits 100 million doses of vaccines every year to Biocon Biologics

The Hindu  

Biocon Biologics Limited will offer approximately 15% stake to Serum Institute Life Sciences Private Limited at a post-money valuation of $4.9 billion in exchange for committed access to 100 million doses of vaccines per annum for 15 years, primarily from SILS’s upcoming vaccine facility in Pune with commercialisation rights of the SILS vaccine portfolio, including COVID-19 vaccines, for global markets. Biocon Biologics Limited is a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited is a subsidiary of Serum Institute of India. Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics, said, “This alliance will complement the strengths and resources of the two leading players in vaccines and biologics.'' Adar Poonawalla, CEO, Serum Institute of India, said, “We look forward to complementing each other’s capabilities and capacities in vaccines and biologics with the objective of addressing inequitable access, both in emerging and developed markets, for life-saving vaccines and biologics.” Mr. Poonawalla will get a seat on the board of Biocon Biologics Limited.

Vaccines Bbl Vaccine Poonawalla Serum Institute Biocon Biologics Biologics Biocon Biocon Biologics Limited  bbl  poonawalla  sils  vaccines  doses  serum  limited  institute  subsidiary  100  adar  biologics  biocon  vaccine  million  commits

History of this topic

Serum Institute to double investment in Biocon’s unit to $300 million
1 year, 7 months ago

Serum Institute to double investment in Biocon’s unit to $300 million

Live Mint  

As part of its expansion of investment in one of Biocon Ltd's units, Serum Institute of Life Sciences will give it access to 100 million vaccine doses annually. As per the new alliance, the company would pump in $150 million after converting a loan to Biocon Pharma Limited into equity in Biocon Biologics Ltd. The investment made is in addition …

'Will boost vaccine production': Poonawalla thanks Jaishankar, Biden for policy change
3 years, 6 months ago

'Will boost vaccine production': Poonawalla thanks Jaishankar, Biden for policy change

India TV News  

Serum Institute of India CEO Adar Poonawalla has thanked US President Joe Biden, External Affairs Minister S Jaishankar for policy change with respect to raw material needed for vaccine production saying it will boost manufacturing and strengthen fight against Covid. Taking to Twitter, SII CEO Adar Poonawalla said, "Thanks to the efforts of @POTUS, @WhiteHouse, & @DrSJaishankar, this policy change …

Serum Institute Disassociates Itself from Its Executive's Remarks on Covid Vaccination Drive
3 years, 7 months ago

Serum Institute Disassociates Itself from Its Executive's Remarks on Covid Vaccination Drive

News 18  

The Serum Institute has disassociated itself from its executive director's statement that the government began the COVID-19 vaccination of multiple age groups without taking into consideration the available stock, stating that this is "not the view of the company". In a letter to the Union Health Ministry on May 22, Prakash Kumar Singh, Director of Government and Regulatory Affairs at …

'Used to Pressure': Inside the World's Biggest Vaccine Factory, India's Serum Institute
3 years, 10 months ago

'Used to Pressure': Inside the World's Biggest Vaccine Factory, India's Serum Institute

News 18  

The tiny clinking vials supervised by silent PPE-wearing technicians belie the excitement inside the world’s largest vaccine manufacturer, the Serum Institute of India, a major player in the fight against coronavirus. With Poonawalla vowing to reserve 50 percent of Covishield stocks for the Indian market, New Delhi, which intends to immunise 300 million people by July, is engaging in a …

Govt's SII Deal, Bharat Biotech Vaccines: Free Doses, PM CARES Funding, Role of Condom-Maker PSU
3 years, 11 months ago

Govt's SII Deal, Bharat Biotech Vaccines: Free Doses, PM CARES Funding, Role of Condom-Maker PSU

News 18  

After days of hectic negotiations, discussions on pricing and much back and forth, India has finally inked two vaccine deals. Bharat Biotech International Limited signed a deal with the central government on January 11 to supply 55 lakh doses of its inactivated vaccine called Covaxin. SII to supply 4.5 cr doses, Bharat Biotech 38.5 lakh SII will supply a total …

Serum Institute of India Says Covid-19 Vaccine Likely to Be Ready by End of 2020, Final Pricing in 2 Months
4 years, 4 months ago

Serum Institute of India Says Covid-19 Vaccine Likely to Be Ready by End of 2020, Final Pricing in 2 Months

News 18  

Adar Poonawalla, Chief Executive Officer of Pune-based Serum Institute of India, has said the coronavirus vaccine may be ready by the end of this year and that the final price of the anti-virus dose will be announced in two months. We will conduct trials in India on a few thousand patients in partnership with the Indian Council of Medical Research," …

Gates, Gavi in tie-up with Serum Institute
4 years, 4 months ago

Gates, Gavi in tie-up with Serum Institute

Live Mint  

The Bill and Melinda Gates Foundation, along with Gavi-The Vaccine Alliance, will provide at-risk funding of $150 million to Serum Institute of India to support the production of two promising vaccines by University of Oxford and Novavax on the condition that the Pune-based firm prices the two vaccines at a maximum of $3 per dose. Under the pact, Serum Institute …

Covid-19 vaccine: Adar Poonawalla to keep ‘more than enough’ vaccine for Parsis
4 years, 4 months ago

Covid-19 vaccine: Adar Poonawalla to keep ‘more than enough’ vaccine for Parsis

Live Mint  

Serum Institute of India chief executive officer Adar Poonawalla said 'more than enough' doses of coronavirus vaccine will be reserved for the Parsi community. Serum Institute of India, which has partnered with AstraZeneca for manufacturing the Oxford vaccine candidate for COVID-19, has sought permission from the Drugs Controller General of India for conducting phase 2 and 3 human clinical trials …

5,000 Indians to enrol for Oxford vaccine trials: Adar Poonawalla
4 years, 5 months ago

5,000 Indians to enrol for Oxford vaccine trials: Adar Poonawalla

Live Mint  

Serum Institute of India is now preparing for the phase 3 clinical trials of the covid-19 vaccine candidate developed by the University of Oxford, after interim data from a clinical study published in The Lancet journal on Monday showed that it was safe and provided dual immunity against the fatal respiratory disease. In an interview with Mint, Serum Institute of …

Discover Related